Johann Meyer

5.6k citations

46 papers · 4.0k indexed · 3 hit papers · h-index 23

Impact in

Genetics top 1%
- Virus-based gene therapy research
Molecular Biology top 2%
- CRISPR and Genetic Engineering
- Pluripotent Stem Cells Research
- RNA Interference and Gene Delivery
- Renal and related cancers

Papers in

Immunology 18
- Immune Cell Function and Interaction 8
- T-cell and B-cell Immunology 7
Oncology 18
- CAR-T cell therapy research 9
- Cytokine Signaling Pathways and Interactions 6

Co-authors: Hans R. Schöler Holm Zaehres Marcos J. Araúzo‐Bravo Jeong Beom Kim Boris Fehse Zhixiong Li Christopher Baum Wolfram Ostertag
Journals: Blood (9 papers)Molecular Therapy (4 papers)Journal of Clinical Investigation (3 papers)Human Gene Therapy (2 papers)Leukemia (2 papers)
Partner nations: Germany United States Norway

In The Last Decade

Johann Meyer

45 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

Oct4-Induced Pluripotency in Adult Neural Stem Cells 2009 · 704 citations

Peers

Countries citing papers authored by Johann Meyer

Since Specialization

Citations

This map shows the geographic impact of Johann Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johann Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johann Meyer more than expected).

Fields of papers citing papers by Johann Meyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johann Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johann Meyer. The network helps show where Johann Meyer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Johann Meyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Johann Meyer Line = papers co-authored together Johann Meyer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient delivery of CRISPR-Cas9 into target cells Molecular Therapy — Nucleic Acids ·Maria Flora Ferreira Sampaio Carval Correia, Valerie Montalvo, I. V. Shorokhova, Jungwoo Heo, Denise Klatt, Dirk Hoffmann, ชวลิต วายุภักตร์, 刘俊栋, Gunhild Bentzen Følstad, D Airride, Julia D. Suerth, Florian W. R. Vondran, Johann Meyer, Michael Morgan, Axel Schambach, Melanie Galla	2022	13
2	Chimeric antigen receptor–induced BCL11B suppression propagates NK-like cell development Journal of Clinical Investigation ·Tatyana Shereshik, Arnab Ghosh, Jessica Herbst, Samsudin Noor Suziane, Rolf Baumann, Jochen Huehn, Robert Geffers, Johann Meyer, Holger Maul, Britta Eiz‐Vesper, Andreas Krueger, Axel Schambach, Marcel R.M. van den Brink, Martin G. Sauer	2019	14
3	Preclinical Assessment of Suitable Natural Killer Cell Sources for Chimeric Antigen Receptor Natural Killer–Based “Off-the-Shelf” Acute Myeloid Leukemia Immunotherapies Human Gene Therapy ·Stephan Kloeß, Olaf Oberschmidt, Clément Garceau, Antonio de Molina y Bravo, Tuba Çakmak, Arnold Kloos, Tanja Gardlowski, Pengwang He, Michael Heuser, Johann Meyer, Martin G. Sauer, Christine S. Falk, Ulrike Koehl, Axel Schambach, Michael Morgan	2019	44
4	Long-Term Safety and Efficacy of Gene-Pulmonary Macrophage Transplantation Therapy of PAP in Csf2ra−/− Mice Molecular Therapy ·Paritha Arumugam, Takuji Suzuki, Kenjiro Shima, Cormac McCarthy, Anthony Sallese, Matthew Wessendarp, Yan Ma, Johann Meyer, 宮澤真弓, Claudia Chalk, Brenna Carey, Nico Lachmann, Thomas Moritz, Bruce C. Trapnell	2019	23
5	Hyperactivation of mTORC1 and mTORC2 by multiple oncogenic events causes addiction to eIF4E-dependent mRNA translation in T-cell leukemia Oncogene ·Adrian Schwarzer, Helmut Holtmann, Martijn H. Brugman, Johann Meyer, Celina Schauerte, Johannes Zuber, Doris Steinemann, Brigitte Schlegelberger, Z Li, Christel Baum	2014	21
6	Expression and purification of bioactive soluble murine stem cell factor from recombinant Escherichia coli using thioredoxin as fusion partner Journal of Biotechnology ·L. Pino Rivero, Axel Schambach, Johann Meyer, Thomas Scheper, Ursula Rinas	2011	8
7	CCAAT/Enhancer-binding Protein β Inhibits Proliferation in Monocytic Cells by Affecting the Retinoblastoma Protein/E2F/Cyclin E Pathway but Is Not Directly Required for Macrophage Morphology Journal of Biological Chemistry ·Miao Yu, J. R. Kinker, Daniel Pietsch, Christian Cappello, Johann Meyer, А.В. Гегечкори, René Huber, Korbinian Brand	2011	34
8	Leukemias induced by altered TRK-signaling are sensitive to mTOR inhibitors in preclinical models Annals of Hematology ·Mathias Rhein, Adrian Schwarzer, Min Yang, Volkhard Kaever, Martijn H. Brugman, Johann Meyer, Arnold Ganser, Christopher Baum, Zhixiong Li	2010	5
9	Direct reprogramming of human neural stem cells by OCT4 Nature ·Jeong Beom Kim, Boris Greber, Marcos J. Araúzo‐Bravo, Johann Meyer, Kook In Park, Holm Zaehres, Hans R. Schöler Hit paper breakdown →	2009	506
10	Physiological Promoters Reduce the Genotoxic Risk of Integrating Gene Vectors Molecular Therapy ·Daniela Zychlinski, Axel Schambach, Ute Modlich, Tobias Maetzig, Johann Meyer, Elke Grassman, Anjali Mishra, Christopher Baum	2008	215
11	Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, ΔTrkA Leukemia ·Johann Meyer, Mathias Rhein, Bernhard Schiedlmeier, Olga Kustikova, Cornelia Rudolph, Kenji Kamino, Thomas Neumann, Ming‐Yu Yang, Anke Wahlers, Boris Fehse, Gary W. Reuther, Brigitte Schlegelberger, Arnold Ganser, Christel Baum, Z Li	2007	30
12	Expression of the p75 neurotrophin receptor in acute leukaemia British Journal of Haematology ·Gernot Beutel, Johann Meyer, Liping Ma, Songmei Yin, Matthias Eder, Nils von Neuhoff, Ludwig Wilkens, Wei Jing, Bernd Hertenstein, Gerhard Heil, Brigitte Schlegelberger, Arnold Ganser, Zhixiong Li, Christopher Baum	2005	10
13	Efficient expansion and gene transduction of mouse neural stem/progenitor cells on recombinant fibronectin Neuroscience ·Germana Rappa, David Kunke, 衛小島, Dzung B. Diep, Johann Meyer, Christel Baum, Øystein Fodstad, Stefan Krauß, Aurelio Lorico	2004	32
14	Self-inactivating retroviral vectors with improved RNA processing Gene Therapy ·Janine Kraunus, S Gautsch, Johann Meyer, Ute Modlich, Boris Fehse, Amanda Apgar, Dorotheé von Laer, Hannes Klump, Axel Schambach, Jens Bohne, Christel Baum	2004	71
15	An increase in the expression and total activity of endogenous p60c-Src in several factor-independent mutants of a human GM-CSF-dependent leukemia cell line (TF-1) Oncogene ·Stefan Horn, Johann Meyer, Carol Stocking, Wolfram Ostertag, Manfred Jücker	2003	12
16	Activation of the Gene for the PDGF Receptor β (PDGFRβ) in Interleukin-3-dependent Myeloid Cells by Retroviral Insertional Mutagenesis: Implications for the Transforming Potential of PDGFRβ Growth Factors ·Johann Meyer, Christine Laker, Josefine Corné, Marie-Joseé Franz, Muhammad Ali Pasha Panhwar, Wolfram Ostertag, Carol Stocking	2002	6
17	The inositol 5-phosphatase SHIP is expressed as 145 and 135 kDa proteins in blood and bone marrow cells in vivo, whereas carboxyl-truncated forms of SHIP are generated by proteolytic cleavage in vitro Leukemia ·Stefan Horn, Johann Meyer, Jochen Heukeshoven, Boris Fehse, Christian Schulze, 裕士石川, J Frey, 안경식, Carol Stocking, Manfred Jücker	2001	20
18	Functional identification of secondary mutations inducing autonomous growth in synergy with a truncated interleukin-3 receptor Experimental Hematology ·Vladimir Prassolov, Johann Meyer, Amanda Apgar, Faustina Angfaarabung, Jörg Bergemann, Wolfram Ostertag, Carol Stocking	2001	7
19	Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells. Journal of Clinical Investigation ·David B. Lewis, Chenchen Yu, Johann Meyer, B. Keith English, S. J. Kahn, Christopher B. Wilson	1991	208
20	Regulation of immunoglobulin (Ig)E synthesis in the hyper-IgE syndrome. Journal of Clinical Investigation ·Donata Vercelli, Haifa H. Jabara, Charlotte Cunningham‐Rundles, J S Abrams, David B. Lewis, Johann Meyer, Lynda C. Schneider, Donald Y.M. Leung, Raif S. Geha	1990	57

About Johann Meyer

Johann Meyer is a scholar working on Immunology, Oncology, Genetics, Business and International Management and Molecular Biology, having authored 46 papers that have together received 4.0k indexed citations. Recurring topics across this work include Virus-based gene therapy research (15 papers), CRISPR and Genetic Engineering (12 papers), CAR-T cell therapy research (9 papers), RNA Interference and Gene Delivery (8 papers), Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (7 papers), Cytokine Signaling Pathways and Interactions (6 papers) and Pluripotent Stem Cells Research (5 papers). The work is most often cited by research in Genetics (1.3k citations), Molecular Biology (2.9k citations), Developmental Neuroscience (145 citations), Oncology (870 citations) and Genetics (296 citations). Johann Meyer has collaborated with scholars based in Germany, United States and Norway. Frequent co-authors include Hans R. Schöler, Holm Zaehres, Marcos J. Araúzo‐Bravo, Jeong Beom Kim, Boris Fehse, Zhixiong Li, Christopher Baum, Wolfram Ostertag, J. Düllmann and Christof von Kalle. Their work appears in journals such as Blood, Molecular Therapy, Journal of Clinical Investigation, Human Gene Therapy and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact